Hokkanen L, Launes J
Institute of Neuroscience, Department of Neurology, University of Helsinki, Finland.
J Neurol Neurosurg Psychiatry. 1997 Aug;63(2):222-7. doi: 10.1136/jnnp.63.2.222.
Follow up of cognitive sequelae of acute encephalitis and estimation of the frequency of persisting dementia.
Out of a series of 45 consecutive patients with acute encephalitis prospectively studied in 1990-95, 40 were screened for difficulty in everyday life using the Blessed dementia scale (BDS) 3.7 (1.4), mean (SD), years after onset. Eight patients had had herpes simplex encephalitis (HSVE), 16 some other identified aetiology, and in 21 the aetiology was unknown. All, except two patients with a nonherpetic encephalitis, were treated with acyclovir. All patients with disability in BDS (12/40), were invited to a neuropsychological reassessment, and the results of this assessment were compared with those of a similar assessment done after the acute stage. At follow up one patient could not complete the tests due to intractable epilepsy.
In six of 11 cases the symptoms causing disability were mainly psychiatric. Five patients (two with HSVE) had a pronounced memory impairment together with other cognitive deficits, indicating dementia (frequency of 12.8%). In eight of the 11 testable cases cognitive performance had improved over the years, in two cases a decline was found and one patient with severe deficits showed no change. Intractable epilepsy was found in four of 12 cases.
Cognitive decline had taken place already at the acute stage, and further deterioration was uncommon. Considerable improvement occurred in most patients during follow up. Also in patients with HSVE treated with acyclovir the cognitive recovery was substantial and of a magnitude not expected based on previous literature. Intractable epilepsy contributed to the cognitive deterioration in some cases. Affective disorders also had a surprisingly important role for the long term outcome.
对急性脑炎的认知后遗症进行随访,并评估持续性痴呆的发生率。
在1990年至1995年对45例连续的急性脑炎患者进行前瞻性研究,其中40例在发病3.7(1.4)年(均值[标准差])后使用布氏痴呆量表(BDS)筛查日常生活困难情况。8例患有单纯疱疹病毒性脑炎(HSVE),16例有其他明确病因,21例病因不明。除2例非疱疹性脑炎患者外,所有患者均接受阿昔洛韦治疗。所有BDS评定为残疾的患者(12/40)均被邀请进行神经心理学重新评估,并将该评估结果与急性期后进行的类似评估结果进行比较。随访时,1例患者因难治性癫痫无法完成测试。
11例中有6例导致残疾的症状主要为精神方面的。5例患者(2例患有HSVE)存在明显的记忆障碍及其他认知缺陷,提示为痴呆(发生率为12.8%)。11例可测试病例中有8例认知表现多年来有所改善,2例出现下降,1例有严重缺陷者无变化。12例中有4例发现难治性癫痫。
认知衰退在急性期就已发生,进一步恶化并不常见。大多数患者在随访期间有显著改善。接受阿昔洛韦治疗的HSVE患者认知恢复也很显著,程度超出既往文献预期。难治性癫痫在某些情况下导致认知恶化。情感障碍对长期预后也有着惊人的重要作用。